Google’s Quantum AI division is teaming with pharmaceutical company Boehringer Ingelheim to develop new types of drugs using Quantum Computing.
The idea is to research and develop quantum computing tech to do molecular dynamics simulations, or the study of how molecules and atoms move.
The new partnership combines Boehringer Ingelheim’s leading expertise in the field of computer-aided drug design and in silico modeling with Google’s outstanding resources as one of the leading developers of quantum computers and algorithms.
Boehringer Ingelheim will invest significantly in the coming years to realize the full potential of Quantum Computing. The company has already set up a dedicated Quantum Lab and hired outstanding experts in the field of Quantum Computing from academia, industry, and quantum providers.
Boehringer Ingelheim is the first pharmaceutical company worldwide to join forces with Google in Quantum Computing.
The partnership is designed for three years and is co-led by the newly established Quantum Lab of Boehringer Ingelheim.
The post Google and Boehringer Ingelheim partnership appeared first on Swiss Quantum Hub.
